92 related articles for article (PubMed ID: 9149199)
1. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy.
Sharma VK; Heinzelmann EJ; Steinberg EN; Vasudeva R; Howden CW
Am J Gastroenterol; 1997 May; 92(5):848-51. PubMed ID: 9149199
[TBL] [Abstract][Full Text] [Related]
2. Simplified lansoprazole suspension--a liquid formulation of lansoprazole--effectively suppresses intragastric acidity when administered through a gastrostomy.
Sharma VK; Vasudeva R; Howden CW
Am J Gastroenterol; 1999 Jul; 94(7):1813-7. PubMed ID: 10406240
[TBL] [Abstract][Full Text] [Related]
3. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules.
Sharma VK; Ugheoke EA; Vasudeva R; Howden CW
Aliment Pharmacol Ther; 1998 Nov; 12(11):1171-4. PubMed ID: 9845407
[TBL] [Abstract][Full Text] [Related]
4. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Balaban DH; Duckworth CW; Peura DA
Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
[TBL] [Abstract][Full Text] [Related]
5. The effects on intragastric acidity of per-gastrostomy administration of an alkaline suspension of omeprazole.
Sharma VK; Vasudeva R; Howden CW
Aliment Pharmacol Ther; 1999 Aug; 13(8):1091-5. PubMed ID: 10468686
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
7. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Javsicas LH; Sanchez LC
Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
[TBL] [Abstract][Full Text] [Related]
8. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
10. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls.
Kuo B; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1532-8. PubMed ID: 8759656
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
Sharma VK
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
[TBL] [Abstract][Full Text] [Related]
12. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
13. [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].
Nie Y; Li Y; Sha W; Dai S; She Q; Wu H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):520-2. PubMed ID: 11809113
[TBL] [Abstract][Full Text] [Related]
14. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
15. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
16. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
[TBL] [Abstract][Full Text] [Related]
17. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
18. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
Tolbert K; Bissett S; King A; Davidson G; Papich M; Peters E; Degernes L
J Vet Intern Med; 2011; 25(1):47-54. PubMed ID: 21143305
[TBL] [Abstract][Full Text] [Related]
20. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]